471 related articles for article (PubMed ID: 19195886)
1. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.
Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P
Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886
[TBL] [Abstract][Full Text] [Related]
2. Macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors with activity in vivo.
Machauer R; Laumen K; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Jaton AL; Desrayaud S; Staufenbiel M; Rabe S; Paganetti P; Neumann U
Bioorg Med Chem Lett; 2009 Mar; 19(5):1366-70. PubMed ID: 19195887
[TBL] [Abstract][Full Text] [Related]
3. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
[TBL] [Abstract][Full Text] [Related]
4. Macrocyclic statine-based inhibitors of BACE-1.
Barazza A; Götz M; Cadamuro SA; Goettig P; Willem M; Steuber H; Kohler T; Jestel A; Reinemer P; Renner C; Bode W; Moroder L
Chembiochem; 2007 Nov; 8(17):2078-91. PubMed ID: 17963207
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
[TBL] [Abstract][Full Text] [Related]
9. 2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead.
Baxter EW; Conway KA; Kennis L; Bischoff F; Mercken MH; Winter HL; Reynolds CH; Tounge BA; Luo C; Scott MK; Huang Y; Braeken M; Pieters SM; Berthelot DJ; Masure S; Bruinzeel WD; Jordan AD; Parker MH; Boyd RE; Qu J; Alexander RS; Brenneman DE; Reitz AB
J Med Chem; 2007 Sep; 50(18):4261-4. PubMed ID: 17685503
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of potent and selective BACE-1 inhibitors.
Björklund C; Oscarson S; Benkestock K; Borkakoti N; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist A; Samuelsson B
J Med Chem; 2010 Feb; 53(4):1458-64. PubMed ID: 20128595
[TBL] [Abstract][Full Text] [Related]
11. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
[TBL] [Abstract][Full Text] [Related]
12. Macrocyclic BACE-1 inhibitors acutely reduce Abeta in brain after po application.
Lerchner A; Machauer R; Betschart C; Veenstra S; Rueeger H; McCarthy C; Tintelnot-Blomley M; Jaton AL; Rabe S; Desrayaud S; Enz A; Staufenbiel M; Paganetti P; Rondeau JM; Neumann U
Bioorg Med Chem Lett; 2010 Jan; 20(2):603-7. PubMed ID: 19963375
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1.
Barrow JC; Rittle KE; Ngo PL; Selnick HG; Graham SL; Pitzenberger SM; McGaughey GB; Colussi D; Lai MT; Huang Q; Tugusheva K; Espeseth AS; Simon AJ; Munshi SK; Vacca JP
ChemMedChem; 2007 Jul; 2(7):995-9. PubMed ID: 17458843
[No Abstract] [Full Text] [Related]
14. Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.
Malamas MS; Erdei J; Gunawan I; Barnes K; Johnson M; Hui Y; Turner J; Hu Y; Wagner E; Fan K; Olland A; Bard J; Robichaud AJ
J Med Chem; 2009 Oct; 52(20):6314-23. PubMed ID: 19757823
[TBL] [Abstract][Full Text] [Related]
15. Macrocyclic peptidomimetic inhibitors of beta-secretase (BACE): first X-ray structure of a macrocyclic peptidomimetic-BACE complex.
Rojo I; Martín JA; Broughton H; Timm D; Erickson J; Yang HC; McCarthy JR
Bioorg Med Chem Lett; 2006 Jan; 16(1):191-5. PubMed ID: 16249081
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.
Malamas MS; Erdei J; Gunawan I; Turner J; Hu Y; Wagner E; Fan K; Chopra R; Olland A; Bard J; Jacobsen S; Magolda RL; Pangalos M; Robichaud AJ
J Med Chem; 2010 Feb; 53(3):1146-58. PubMed ID: 19968289
[TBL] [Abstract][Full Text] [Related]
17. Macrocyclic inhibitors of beta-secretase: functional activity in an animal model.
Stachel SJ; Coburn CA; Sankaranarayanan S; Price EA; Wu G; Crouthamel M; Pietrak BL; Huang Q; Lineberger J; Espeseth AS; Jin L; Ellis J; Holloway MK; Munshi S; Allison T; Hazuda D; Simon AJ; Graham SL; Vacca JP
J Med Chem; 2006 Oct; 49(21):6147-50. PubMed ID: 17034118
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, SAR, and X-ray structure of human BACE-1 inhibitors with cyclic urea derivatives.
Park H; Min K; Kwak HS; Koo KD; Lim D; Seo SW; Choi JU; Platt B; Choi DY
Bioorg Med Chem Lett; 2008 May; 18(9):2900-4. PubMed ID: 18434152
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of potent macrocyclic renin inhibitors.
Sund C; Belda O; Wiktelius D; Sahlberg C; Vrang L; Sedig S; Hamelink E; Henderson I; Agback T; Jansson K; Borkakoti N; Derbyshire D; Eneroth A; Samuelsson B
Bioorg Med Chem Lett; 2011 Jan; 21(1):358-62. PubMed ID: 21112780
[TBL] [Abstract][Full Text] [Related]
20. Probing pockets S2-S4' of the gamma-secretase active site with (hydroxyethyl)urea peptidomimetics.
Esler WP; Das C; Wolfe MS
Bioorg Med Chem Lett; 2004 Apr; 14(8):1935-8. PubMed ID: 15050631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
